Sotera Health (SHC) is a US-listed Healthcare company in Medical - Diagnostics & Research with a market capitalization of $4.9B, trading at
7.32 on the NASDAQ. This SniperIQ fundamentals page covers Sotera Health's valuation (P/E 42.1x, P/B 7.9x), profitability (net margin 9.9%), revenue (
.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap$4.9B
P/E (TTM)42.1x
Net Margin9.9%
Revenue (FY25)
.2B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Sotera Health's market cap?
Sotera Health (SHC) has a market capitalization of approximately $4.9B, trading at
7.32 on the NASDAQ. Market cap moves with the live share price.
What is Sotera Health's P/E ratio?
Sotera Health's trailing twelve-month P/E ratio is 42.1x, with a price-to-book (P/B) of 7.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Sotera Health?
Sotera Health runs a net profit margin of 9.9%, a gross margin of 55.0%, and an operating margin of 35.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sotera Health generate?
Sotera Health reported revenue of
.2B for fiscal year 2025, with net income of $78M and earnings per share (EPS) of 0.27. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sotera Health pay a dividend?
Sotera Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Sotera Health financially healthy?
Sotera Health carries a debt-to-equity ratio of 3.65x and a current ratio of 2.82x, with a market beta of 1.77. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sotera Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sotera Health (SHC) the key facts are: market cap $4.9B, P/E 42.1x, revenue
.2B, 52-week range 11-19.85. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Sotera Health's full fundamentals live
Get Sotera Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.